| Literature DB >> 35426503 |
Rasmus F W Olander1,2, Linda Litwin3,4, Johnny K M Sundholm5,3, Taisto Sarkola5,3.
Abstract
Studies examining the link between abnormal fetal growth and cardiac changes in childhood have presented conflicting results. We studied the effect of abnormal fetal growth on cardiac morphology and function during childhood, while controlling for body size, composition and postnatal factors. We report on the follow-up of 90 children (median age 5.81 years, IQR 5.67; 5.95) born appropriate for gestational age (AGA, N = 48), small for gestational age (SGA, N = 23), or large for gestational age (LGA, N = 19); SGA and LGA defined as birth weight Z-score < - 2 and > + 2, respectively. We examined the heart using echocardiography, including Doppler and strain imaging, in relation to anthropometrics, body composition, blood pressure, physical activity, and diet. Although groupwise differences in body size decreased during the first year after birth, LGA remained larger at follow-up, with higher lean body mass and BMI, while SGA were smaller. Slight changes in left ventricular diastolic function were present in SGA and LGA, with SGA showing increased mitral diastolic E- and A-wave peak flow velocities, and increased septal E/E' ratio, and LGA showing larger left atrial volume adjusted for sex and lean body mass. In univariate analyses, lean body mass at follow-up was the strongest predictor of cardiac morphology. We found no groupwise differences at follow-up for ventricular sphericity, cardiac morphology adjusted for lean body mass and sex, or blood pressure, diet, or physical activity. Cardiac morphology is predicted by lean body mass during childhood, even in the setting of abnormal fetal growth. Our results are consistent with a limited effect of fetal programming on cardiac dimensions during childhood. Minor changes in diastolic function are present in both SGA and LGA children, however, the clinical significance of these changes at this stage is likely small.Entities:
Keywords: Body composition; Cardiovascular disease; child health; Echocardiography; Fetal growth restriction
Mesh:
Year: 2022 PMID: 35426503 PMCID: PMC9349157 DOI: 10.1007/s00380-022-02064-5
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 1.814
Background and anthropometric data for the AGA, SGA, LGA groups at follow-up
| AGA | ( | SGA | ( | LGA | ( | ||
|---|---|---|---|---|---|---|---|
| Maternal pre-pregnancy diabetes | 5 | 0 | 14*** | < 0.001 | |||
| Maternal pre-eclampsia | 3 | 8** | 1 | 0.003 | |||
| Child sex (male/female) | 27/21 | 9/14 | 9/10 | 0.376 | |||
| Gestational age (weeks) | 34.9 | 34.1; 39.3 | 37.6 | 34.6; 38.1 | 35.7 | 34.6; 37.6 | 0.602 |
| Birth weight (g) | 2550 | 2195; 3474 | 2005*** | 1735; 2390 | 4060*** | 3740; 4480 | < 0.001 |
| Birth weight ( | 0.06 | − 0.69; 0.85 | − 2.67*** | − 2.86; − 1.97 | 3.87*** | 3.10; 4.13 | < 0.001 |
| Weight at 1 y ( | − 0.03 | ± 1.01 | − 0.98** | ± 1.30 | 0.39 | ± 0.76 | < 0.001 |
| Age at follow-up (years) | 5.8 | 5.7; 5.9 | 5.8 | 5.7; 6.1 | 5.8 | 5.7; 5.9 | 0.776 |
| Height (cm) | 116.8 | ± 4.5 | 111.8*** | ± 4.5 | 117.5 | ± 3.6 | < 0.001 |
| Height ( | − 0.03 | ± 0.90 | − 1.15*** | ± 1.06 | 0.18 | ± 0.65 | < 0.001 |
| Weight (kg) | 20.1 | 18.0; 22.3 | 17.9** | 15.2; 20.7 | 22.6** | 21.2; 23.9 | < 0.001 |
| Weight ( | − 0.83 | ± 1.28 | − 1.48 | ± 2.02 | 0.38*** | ± 1.03 | < 0.001 |
| BMI (kg/m2) | 14.9 | 14.0; 15.7 | 13.9 | 13.1; 15.9 | 16.1** | 15.3; 16.9 | < 0.001 |
| BMI ( | − 0.80 | ± 1.29 | − 1.38 | ± 1.92 | 0.38*** | ± 1.04 | < 0.001 |
| Body surface area (m2) | 0.81 | ± 0.07 | 0.75** | ± 0.08 | 0.86* | ± 0.08 | < 0.001 |
| Thoracic circumference (cm) | 56.4 | 54.0; 57.8 | 53.5** | 50.0; 56.1 | 57.7 | 55.5; 61.0 | < 0.001 |
| Lean body mass (kg) | 17.7 | ± 1.9 | 15.8*** | ± 1.8 | 18.9* | ± 1.6 | < 0.001 |
| Body fat (%) | 13 | 9; 16 | 8 | 4; 15 | 15 | 12; 18 | 0.046 |
| Systolic BP (mmHg) | 101 | ± 7 | 102 | ± 10 | 100 | ± 6 | 0.790 |
| Systolic BP ( | 0.65 | ± 0.67 | 0.85 | ± 0.88 | 0.53 | ± 0.66 | 0.334 |
| Diastolic BP (mmHg) | 60 | 56; 65 | 58 | 56; 65 | 58 | 55; 62 | 0.780 |
| Diastolic BP ( | 0.31 | 0.00; 0.95 | 0.36 | 0.15; 0.99 | 0.28 | − 0.08; 0.61 | 0.538 |
| Heart rate (bpm) | 84 | ± 11 | 83 | ± 12 | 81 | ± 8 | 0.514 |
Data are given as mean ± SD, median Q1; Q3 or count. P correspond to ANOVA, Kruskal–Wallis or Fisher–Freeman–Halton exact test, as appropriate. Significant differences in post hoc tests (Dunnet, Games–Howell, Mann–Whitney U, or Z test for proportions) between SGA or LGA and AGA in are indicated with *, **, *** corresponding to two-sided significance levels of < 0.05, < 0.01, and < 0.001. respectively. The significance levels of Mann–Whitney U test and Z test for proportions are Bonferroni-corrected for two group comparisons
AGA appropriate for gestational age; BP blood pressure; LGA large for gestational age; SGA small for gestational age
Cardiac geometry and function for the AGA, SGA and LGA groups
| AGA | ( | SGA | ( | LGA | ( | ||
|---|---|---|---|---|---|---|---|
| Left ventricular basal sphericity index (no unit) | 2.1 | ± 0.2 | 2.2 | ± 0.2 | 2.1 | ± 0.2 | 0.185 |
| Left ventricular mid-papillary sphericity index (no unit) | 1.5 | 1.4; 1.5 | 1.5 | 1.3; 1.6 | 1.5 | 1.4; 1.6 | 0.432 |
| Right ventricular base sphericity index (no unit) | 1.9 | ± 0.2 | 2.0 | ± 0.2 | 1.9 | ± 0.2 | 0.202 |
| Right ventricular mid-cavity sphericity index (no unit) | 2.1 | ± 0.2 | 2.1 | ± 0.2 | 2.1 | ± 0.2 | 0.634 |
| Mitral E-wave peak velocity (cm/s) | 87 | 80; 99 | 99* | 90; 110 | 87 | 81; 98 | 0.013 |
| Mitral A-wave peak velocity (cm/s) | 40 | 32; 50 | 49** | 42; 55 | 41 | 34; 53 | 0.014 |
| Mitral E/A ratio (no unit) | 2.3 | 1.8; 2.7 | 1.9 | 1.8; 2.2 | 2.1 | 1.8; 2.7 | 0.461 |
| Septal | 13 | ± 1 | 13 | ± 1 | 13 | ± 1 | 0.683 |
| Septal | 6.6 | 6.0; 8.1 | 7.5* | 7.0; 8.3 | 6.7 | 6.1; 7.0 | 0.007 |
| Left ventricular ejection fraction (%) | 58 | ± 3 | 57 | ± 4 | 58 | ± 3 | 0.408 |
| Mitral annular plane systolic excursion (cm) | 1.4 | ± 0.2 | 1.3* | ± 0.2 | 1.5 | ± 0.2 | 0.003 |
| Mitral annular plane systolic excursion, indexeda (no unit) | 0.26 | ± 0.03 | 0.24 | ± 0.02 | 0.26 | ± 0.04 | 0.032 |
| Right ventricular fractional area change (%) | 44 | 40; 49 | 41 | 39; 44 | 42 | 40; 46 | 0.129 |
| Tricuspid annular plane systolic excursion (cm) | 2.0 | ± 0.2 | 1.8* | ± 0.2 | 2.0 | ± 0.19 | 0.028 |
| Tricuspid annular plane systolic excursion, indexeda (no unit) | 0.40 | ± 0.05 | 0.38 | ± 0.05 | 0.39 | ± 0.06 | 0.333 |
Data are given as mean ± SD or median Q1; Q3. P correspond to ANOVA or Kruskal–Wallis test, as appropriate. Significant differences in post hoc tests (Dunnet or Mann–Whitney U) between SGA or LGA and AGA are indicated with * and **, corresponding to two-sided significance levels of < 0.05 and < 0.01, respectively. The significance level of Mann–Whitney U test is Bonferroni-corrected for two group comparisons. AGA appropriate for gestational age; LGA large for gestational age: SGA small for gestational age
aDivided by corresponding ventricle length
Fig. 1Aortic valve diameter, left ventricular mass and volume plotted against lean body mass and body surface area. AGA indicates appropriate for gestational age, SGA small for gestational age, LGA large for gestational age. Data are presented with a linear regression line with 95% confidence interval bands, and with Pearson’s correlation coefficient, r
Cardiovascular morphology for the AGA, SGA and LGA groups with adjusted means for sex and lean body mass
| AGA | ( | SGA | ( | LGA | ( | ||
|---|---|---|---|---|---|---|---|
| Abdominal aorta diameter (cm) | 0.80 | (0.01) | 0.79 | (0.02) | 0.83 | (0.02) | 0.218 |
| Aortic proximal arch diameter (cm) | 1.53 | (0.03) | 1.51 | (0.05) | 1.51 | (0.05) | 0.900 |
| Aortic distal arch diameter (cm) | 1.19 | (0.02) | 1.22 | (0.03) | 1.17 | (0.03) | 0.544 |
| Aortic isthmus diameter (cm) | 1.11 | (0.02) | 1.07 | (0.04) | 1.12 | (0.04) | 0.661 |
| Aortic valve diameter (cm) | 1.38 | (0.02) | 1.35 | (0.02) | 1.34 | (0.03) | 0.574 |
| Aortic root diameter (cm) | 1.86 | (0.03) | 1.87 | (0.04) | 1.84 | (0.05) | 0.877 |
| Aortic sinotubular junction diameter (cm) | 1.61 | (0.02) | 1.67 | (0.040) | 1.62 | (0.04) | 0.360 |
| Pulmonary valve diameter (cm) | 1.90 | (0.03) | 1.82 | (0.05) | 1.86 | (0.05) | 0.437 |
| Left ventricular end-diastolic diameter (cm) | 3.7 | (0.0) | 3.8 | (0.1) | 3.6 | (0.1) | 0.049 |
| Left ventricular mass (g) | 41 | (1) | 44 | (2) | 39 | (2) | 0.254 |
| Left ventricular length (cm) | 5.5 | (0.1) | 5.6 | (0.1) | 5.5 | (0.1) | 0.553 |
| Left ventricular base (cm) | 2.6 | (0.0) | 2.5 | (0.0) | 2.6 | (0.0) | 0.783 |
| Left ventricular end-diastolic volume (ml) | 40 | (1) | 42 | (2) | 41 | (2) | 0.715 |
| Left atrial volume (ml) | 18 | (1) | 19 | (1) | 20* | (1) | 0.036 |
| Right ventricular length (cm) | 4.9 | (0.1) | 4.9 | (0.1) | 5.0 | (0.1) | 0.682 |
| Right ventricular base (cm) | 2.6 | (0.0) | 2.5 | (0.0) | 2.7 | (0.1) | 0.304 |
| Right ventricular mid-cavity diameter (cm) | 2.4 | (0.0) | 2.4 | (0.1) | 2.3 | (0.1) | 0.694 |
| Right ventricular diastolic area (cm2) | 10.3 | (0.2) | 10.2 | (0.3) | 10.2 | (0.3) | 0.903 |
| Right atrial area (cm2) | 7.5 | (0.2) | 7.2 | (0.2) | 7.6 | (0.2) | 0.442 |
Data are given as adjusted mean (SE). P corresponds to group as a predictor in ANCOVA. Significant differences in post hoc tests (Fisher's LSD) between AGA and SGA or LGA are indicated with * corresponding to a two-sided significance level of < 0.05. The significance level of Fisher's LSD is corrected for two group comparisons
AGA appropriate for gestational age; LGA large for gestational age; SGA small for gestational age